206 related articles for article (PubMed ID: 23483074)
1. An overview of therapeutic approaches to brain tumor stem cells.
Khoshnevisan A
Med J Islam Repub Iran; 2012 Feb; 26(1):31-40. PubMed ID: 23483074
[TBL] [Abstract][Full Text] [Related]
2. [Stem cells: implications in the development of brain tumors].
Matos Rojas IA; Bertholdo D; Castillo M
Radiologia; 2012; 54(3):221-30. PubMed ID: 22118779
[TBL] [Abstract][Full Text] [Related]
3. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
[TBL] [Abstract][Full Text] [Related]
4. IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.
Shen F; Song C; Liu Y; Zhang J; Wei Song S
Brain Res; 2019 Feb; 1704():174-186. PubMed ID: 30347220
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
6. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
7. [Cancer stem cells in malignant glioma-the mechanism of cancer initiation and the therapeutic development].
Nakano I; Saya H
No Shinkei Geka; 2010 Oct; 38(10):879-89. PubMed ID: 21041889
[TBL] [Abstract][Full Text] [Related]
8. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
Persano L; Rampazzo E; Basso G; Viola G
Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.
Oh MC; Kim JM; Safaee M; Kaur G; Sun MZ; Kaur R; Celli A; Mauro TM; Parsa AT
PLoS One; 2012; 7(10):e47846. PubMed ID: 23110111
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
[TBL] [Abstract][Full Text] [Related]
13. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
14. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
Jhaveri N; Chen TC; Hofman FM
Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells in pediatric brain tumors.
Lasky JL; Choe M; Nakano I
Curr Stem Cell Res Ther; 2009 Dec; 4(4):298-305. PubMed ID: 19500067
[TBL] [Abstract][Full Text] [Related]
16. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.
Spencer DA; Auffinger BM; Murphy JP; Muroski ME; Qiao J; Gorind Y; Lesniak MS
Curr Cancer Drug Targets; 2017; 17(3):236-254. PubMed ID: 27993114
[TBL] [Abstract][Full Text] [Related]
17. Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9.
Joseph JV; van Roosmalen IA; Busschers E; Tomar T; Conroy S; Eggens-Meijer E; Peñaranda Fajardo N; Pore MM; Balasubramanyian V; Wagemakers M; Copray S; den Dunnen WF; Kruyt FA
PLoS One; 2015; 10(12):e0145393. PubMed ID: 26700636
[TBL] [Abstract][Full Text] [Related]
18. Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.
Allani SK; Weissbach H; Lopez Toledano MA
Neoplasma; 2018 Mar; 65(3):376-388. PubMed ID: 29788733
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in glioblastoma.
Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
[TBL] [Abstract][Full Text] [Related]
20. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]